These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1201 related items for PubMed ID: 17962370

  • 21. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q.
    BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091
    [Abstract] [Full Text] [Related]

  • 22. Infections and Kawasaki disease: implications for coronary artery outcome.
    Benseler SM, McCrindle BW, Silverman ED, Tyrrell PN, Wong J, Yeung RS.
    Pediatrics; 2005 Dec 17; 116(6):e760-6. PubMed ID: 16322132
    [Abstract] [Full Text] [Related]

  • 23. Immunoglobulin failure and retreatment in Kawasaki disease.
    Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C.
    Pediatr Cardiol; 2003 Dec 17; 24(2):145-8. PubMed ID: 12457253
    [Abstract] [Full Text] [Related]

  • 24. Clinical responses of patients with Kawasaki disease to different brands of intravenous immunoglobulin.
    Tsai MH, Huang YC, Yen MH, Li CC, Chiu CH, Lin PY, Lin TY, Chang LY.
    J Pediatr; 2006 Jan 17; 148(1):38-43. PubMed ID: 16423595
    [Abstract] [Full Text] [Related]

  • 25. Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review.
    Crayne CB, Mitchell C, Beukelman T.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):77. PubMed ID: 31775898
    [Abstract] [Full Text] [Related]

  • 26. [Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].
    DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF, Beijing Kawasaki Disease Epidemilogy Study Grou.
    Zhonghua Yi Xue Za Zhi; 2007 Nov 27; 87(44):3119-21. PubMed ID: 18269869
    [Abstract] [Full Text] [Related]

  • 27. Pulse methylprednisolone therapy in the treatment of immune globulin-resistant Kawasaki disease: case report and review of the literature.
    Hung JJ, Chiu CH.
    Ann Trop Paediatr; 2004 Mar 27; 24(1):89-93. PubMed ID: 15005973
    [Abstract] [Full Text] [Related]

  • 28. Kawasaki disease: Medical therapies.
    Newburger JW.
    Congenit Heart Dis; 2017 Sep 27; 12(5):641-643. PubMed ID: 28580631
    [Abstract] [Full Text] [Related]

  • 29. Initial intravenous gamma-globulin treatment failure in Iranian children with Kawasaki disease.
    Kashef S, Safari M, Amin R.
    Kaohsiung J Med Sci; 2005 Sep 27; 21(9):401-4. PubMed ID: 16248123
    [Abstract] [Full Text] [Related]

  • 30. Kawasaki disease with lymphadenopathy and fever as sole initial manifestations.
    Kubota M, Usami I, Yamakawa M, Tomita Y, Haruta T.
    J Paediatr Child Health; 2008 Jun 27; 44(6):359-62. PubMed ID: 18476929
    [Abstract] [Full Text] [Related]

  • 31. The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease.
    Kuo HC, Yang KD, Liang CD, Bong CN, Yu HR, Wang L, Wang CL.
    Pediatr Allergy Immunol; 2007 Jun 27; 18(4):354-9. PubMed ID: 17584314
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
    Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M.
    Eur J Pediatr; 2008 Oct 27; 167(10):1119-23. PubMed ID: 18175148
    [Abstract] [Full Text] [Related]

  • 34. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I, Prabhu SS.
    Ann Trop Paediatr; 2009 Mar 27; 29(1):51-3. PubMed ID: 19222935
    [Abstract] [Full Text] [Related]

  • 35. Intravenous immunoglobulin preparation type: association with outcomes for patients with acute Kawasaki disease.
    Manlhiot C, Yeung RS, Chahal N, McCrindle BW.
    Pediatr Allergy Immunol; 2010 May 27; 21(3):515-21. PubMed ID: 20546528
    [Abstract] [Full Text] [Related]

  • 36. Epidemiologic study of Kawasaki disease at a single hospital in Daejeon, Korea (1987 through 2000).
    Lee KY, Han JW, Lee HS, Hong JH, Hahn SH, Lee JS, Whang KT.
    Pediatr Infect Dis J; 2004 Jan 27; 23(1):52-5. PubMed ID: 14743047
    [Abstract] [Full Text] [Related]

  • 37. [Clinical features of recurrent Kawasaki disease in 20 children].
    Zou LX, Gong FQ.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 27; 10(5):617-9. PubMed ID: 18947484
    [Abstract] [Full Text] [Related]

  • 38. Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
    Wallace CA, French JW, Kahn SJ, Sherry DD.
    Pediatrics; 2000 Jun 27; 105(6):E78. PubMed ID: 10835091
    [Abstract] [Full Text] [Related]

  • 39. The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment.
    Durongpisitkul K, Gururaj VJ, Park JM, Martin CF.
    Pediatrics; 1995 Dec 27; 96(6):1057-61. PubMed ID: 7491221
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 61.